MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation ROE Ratio 2011-2026 | BSX
Annual ROE Ratio Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.93 | 8.48 | 8.15 | 3.97 | 6.26 | -0.54 | 33.87 | 19.15 | 1.48 | 5.15 | -3.78 | -1.84 | -1.85 | -59.21 | 3.88 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.87 | -59.21 | 2.34 |
Quarterly ROE Ratio Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.06 | 10.41 | 9.31 | 8.95 | 8.18 | 8.35 | 6.97 | 5.37 | 5.4 | 3.23 | 5.78 | 7.25 | 6.91 | 5.88 | 4.87 | 1.31 | -0.81 | -1.9 | -0.99 | 0.93 | 3.0 | 5.07 | 10.02 | 14.07 | 19.32 | 14.73 | 18.76 | 17.85 | 13.57 | 10.25 | 13.64 | 12.99 | 7.83 | 3.31 | 0.18 | -6.34 | -1.65 | -1.53 | -0.87 | 2.93 | 1.38 | 2.79 | 2.71 | 1.97 | 3.89 | -3.5 | -13.17 | -22.76 | -76.83 | -60.1 | -58.85 | -47.94 | 5.43 | 2.94 | 1.25 | 1.29 | 0.41 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.32 | -76.83 | 0.1 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-0.95 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
-91.15 | $ 11.63 | 3.84 % | $ 329 M | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-1153.69 | $ 8.19 | -0.67 % | $ 1.23 B | USA |
 |
Aziyo Biologics
AZYO
|
192.9 | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-46.5 | $ 4.42 | 4.0 % | $ 165 M |  France |
 |
BioSig Technologies
BSGM
|
-347.45 | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
-20.21 | $ 73.84 | 0.18 % | $ 4.03 B |  Britain |
 |
LENSAR
LNSR
|
131.75 | $ 5.98 | 1.7 % | $ 71.5 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
-13.59 | $ 2.33 | 0.87 % | $ 51.4 M | USA |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-138.88 | $ 0.45 | -3.38 % | $ 28 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-11.44 | $ 18.45 | -0.3 % | $ 433 M | USA |
 |
Delcath Systems
DCTH
|
2.43 | $ 11.41 | 1.6 % | $ 409 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-47.65 | - | - | $ 111 M |  Canada |
 |
Profound Medical Corp.
PROF
|
-64.08 | $ 6.93 | 0.18 % | $ 210 M | Canada |
 |
IRIDEX Corporation
IRIX
|
-90.15 | $ 1.01 | 1.0 % | $ 17.1 M | USA |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
MiMedx Group
MDXG
|
18.94 | $ 3.64 | -4.09 % | $ 538 M | USA |
 |
Pulmonx Corporation
LUNG
|
-99.79 | $ 1.55 | 0.32 % | $ 63.1 M | USA |
 |
Electromed
ELMD
|
17.44 | $ 38.67 | 2.46 % | $ 327 M | USA |
 |
Myomo
MYO
|
-136.8 | $ 0.94 | 2.32 % | $ 39.3 M | USA |
 |
Butterfly Network
BFLY
|
-39.32 | $ 4.49 | 2.05 % | $ 1.11 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
169.16 | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
-353.84 | $ 2.26 | 2.04 % | $ 6.27 M | USA |
 |
Orthofix Medical
OFIX
|
-20.49 | $ 10.09 | -16.95 % | $ 400 M |  Curacao |
 |
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
11.76 | $ 84.17 | 0.19 % | $ 11.4 B | USA |
 |
Insulet Corporation
PODD
|
16.31 | $ 157.39 | 0.51 % | $ 11.1 B | USA |
 |
TransMedics Group
TMDX
|
40.22 | $ 69.01 | 1.48 % | $ 2.35 B | USA |
 |
CONMED Corporation
CNMD
|
4.55 | $ 37.18 | 0.42 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
18.62 | $ 44.57 | 0.95 % | $ 1.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
5.89 | $ 90.03 | -1.53 % | $ 3.13 B | USA |
 |
Invacare Corporation
IVC
|
-25.37 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.38 | $ 83.3 | 0.37 % | $ 48.7 B | USA |